PEN - Penumbra Inc

338.64
-1.980   -0.585%

Share volume: 482,563
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$340.62
-1.98
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
15%
Profitability 3%
Dept financing 10%
Liquidity 53%
Performance 20%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.45%
1 Month
-0.12%
3 Months
14.86%
6 Months
18.58%
1 Year
31.64%
2 Year
38.48%
Key data
Stock price
$338.64
P/E Ratio 
68.52
DAY RANGE
$338.25 - $340.24
EPS 
$4.57
52 WEEK RANGE
$221.26 - $362.41
52 WEEK CHANGE
$31.64
MARKET CAP 
12.176 B
YIELD 
N/A
SHARES OUTSTANDING 
39.243 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-29-2025
BETA 
0.38
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$752,196
AVERAGE 30 VOLUME 
$686,196
Company detail
CEO: Adam Elsesser
Region: US
Website: penumbrainc.com
Employees: 3,900
IPO year: 2015
Issue type: Common Stock
Market: NYSE
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand.

Recent news